The results of UALCAN analysis showed that the expression levels of both IL1RN and PRRX1 were significantly higher in colon and rectal cancer samples than in healthy samples (Figures 5(a), 5(b), 5(c), 5(d), 5(e), 5(f), 5(g), and 5(h)). Here, PRRX1 is linked to rectal cancer.